NASDAQ: QNRXQuoin Pharmaceuticals Ltd Stock Ownership - Who owns Quoin Pharmaceuticals?
Insider buying vs selling
Have Quoin Pharmaceuticals Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dennis Langer | Director | 2025-10-14 | 15,152 | $8.49 | $128.64kBuy |
QNRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when QNRX insiders and whales buy or sell their stock.
QNRX Shareholders
What type of owners hold Quoin Pharmaceuticals Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stonepine Capital Management LLC | 4.65% | 3,271,100 | $15.28M | Insider |
| Michael Myers | 0.86% | 602,808 | $2.82M | Insider |
| Denise P. Carter | 0.86% | 602,648 | $2.81M | Insider |
| Ikarian Capital LLC | 0.30% | 211,538 | $987.88k | Institution |
| Dauntless Investment Group LLC | 0.28% | 196,592 | $918.08k | Institution |
| Gordon Dunn | 0.21% | 151,077 | $705.53k | Insider |
| Anthony James Culverwell | 0.14% | 100,317 | $468.48k | Insider |
| Summittx Capital LP | 0.14% | 100,300 | $468.40k | Institution |
| Velan Capital Investment Management LP | 0.12% | 84,849 | $396.24k | Institution |
| Woodline Partners LP | 0.11% | 79,582 | $371.65k | Institution |
QNRX vs Biotech Stocks
Quoin Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.